SAN MATEO, Calif.--(BUSINESS WIRE)--Allergen Research Corporation (ARC), a privately held biopharmaceutical company developing desensitization treatments for food allergies, today announced the appointments of Mary Rozenman, PhD, as Senior Vice President, Corporate and Commercial Development, and Mike Holfinger, PhD, as Vice President, Manufacturing.